A phase I clinical trial testing the safety of IL-21-expanded, off-the-shelf, natural killer cells for relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.

Sumithira Vasu,Nidhi Sharma,Lynn ODonnell,Kevin Bosse,Dean Anthony Lee

A phase I clinical trial testing the safety of IL-21-expanded, off-the-shelf, natural killer cells for relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.

2020

Sumithira Vasu
Nidhi Sharma
Lynn ODonnell
Kevin Bosse
Dean Anthony Lee

TPS7562Background: Allogeneic transplantation (Allo-HCT) demonstrates the enduring and potent role of the immune system in the control and eradication of acute myeloid leukemia (AML) and myelodyspl...

Keywords:

Oncology
Myeloid leukemia
off the shelf
Phases of clinical research
Pathology
relapsed refractory
Medicine
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations